373
Views
4
CrossRef citations to date
0
Altmetric
Letters to the Editor

High-dose methotrexate-based chemotherapy as treatment for histiocytic sarcoma of the central nervous system

, , , , , , , & show all
Pages 1961-1964 | Received 14 Sep 2015, Accepted 09 Nov 2015, Published online: 04 Jan 2016

References

  • Oberling C. Les réticulosarcomes et les réticuloendothéliosarcomes de la moelle osseuse (sarcomes d’Ewing). Bull Ass Fr Etude Cancer. 1928;17:259–263
  • Rappaport H. Histiocytosis. Tumors of the hematopoietic system. Section 3, fascicle 8. In: Atlas of tumor pathology. Washington, DC: US Armed Forces Institute of Pathology; 1966. p. 241–243.
  • Mathe G, Gerard-Marchant R, Texier JL, et al. The two varieties of lymphoid tissue “reticulosarcomas,” histiocytic and histioblastic types. Br J Cancer. 1970;24:687–695.
  • Weiss LM, Grogan TM, Muller-Hermelink HK, et al. Histiocytic and dendritic cell neoplasms: histiocytic sarcoma. In: Jaffe ES, editor. WHO classification of tumors: pathology and genetics of tumors of haematopoietic and lymphoid tissues. Lyon: International Agency for Research on Cancer Press; 2001. p. 278–319.
  • Grogan TM, Pileri S, Chan JKC, et al. Histiocytic sarcoma. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumors of haematopoietic and lymphoid tissues. Edition 4. Lyon: International Agency for Research on Cancer Press; 2008. p. 356–357.
  • Pileri SA, Grogan TM, Harris NL, et al. Tumours of histiocytes and accessory dendritic cells: an immuohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology. 2002;41:1–29.
  • Vos JA, Abbondanzo SL, Barekman CL, et al. Histiocytic sarcoma: a study of five cases including the histiocyte marker CD163. Modern Pathol. 2005;18:693–704.
  • Kristiansen M, Graverson JH, Jacobsen C, et al. Identification of the haemoglobin scavenger receptor. Nature. 2001;409:198–201.
  • Idbaih A, Mokhtari K, Emile JF, et al. Dramatic res-ponse of a BRAF V600E-mutated primary CNS histiocytic sarcoma to vemurafenib. Neurology. 2014;83:1478–1480.
  • Wei S, Nordberg ML, Fowler MR. Histiocytic sarcoma involving the central nervous system: clinical, immunohistochemical, and molecular genetic studies of a case with review of the literature. Am J Surg Pathol. 2003;27:258–265.
  • Torres CF, Koronies DN, Powers JM, Vadasz AG. Primary leptomeningeal histiocytic lymphoma in a young child. Med Pediatr Oncol. 1996;27:547–550.
  • Cheuk W, Walford N, Lou J, et al. Primary histiocytic lymphoma of the central nervous system. Am J Surg Pathol. 2001;25:1372–1379.
  • Gergis U, Dax H, Ritchie E, et al. Autologous hematopoietic stem-cell transplantation in combination with thalidomide as treatment for histiocytic sarcoma: a case report and review of the literature. J Clin Oncol. 2011;29:e251–e253.
  • Haroche J, Charlotte F, Arnaud L, et al. High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses. Blood. 2012;120:2700–2703.
  • Shao H, Xi L, Raffeld m, et al. Clonally related histocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a study of seven cases. Modern Pathol. 2011;24:1421–1432.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.